Literature DB >> 21321346

Myopathy: five new things.

Björn Oskarsson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321346     DOI: 10.1212/WNL.0b013e31820c3648

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Diagnosis and treatment of inflammatory myopathy: issues and management.

Authors:  Christine Castro; Mark Gourley
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

2.  Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS.

Authors:  Emiliano Trias; Sofía Ibarburu; Romina Barreto-Núñez; Valentina Varela; Ivan C Moura; Patrice Dubreuil; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  JCI Insight       Date:  2017-10-19

3.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04

Review 4.  Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Authors:  Merrilee Needham; Frank L Mastaglia
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

5.  Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.

Authors:  Toshiyuki Sakaeda; Kaori Kadoyama; Yasushi Okuno
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

6.  An EMG-based feature extraction method using a normalized weight vertical visibility algorithm for myopathy and neuropathy detection.

Authors:  Patcharin Artameeyanant; Sivarit Sultornsanee; Kosin Chamnongthai
Journal:  Springerplus       Date:  2016-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.